Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$1.58 - $4.77 $8.14 Million - $24.6 Million
-5,154,155 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$3.74 - $6.28 $207,708 - $348,772
-55,537 Reduced 1.07%
5,154,155 $22.6 Million
Q1 2020

May 15, 2020

BUY
$2.33 - $12.98 $1.06 Million - $5.89 Million
453,692 Added 9.54%
5,209,692 $20.4 Million
Q4 2019

Feb 14, 2020

BUY
$6.75 - $11.15 $10.5 Million - $17.3 Million
1,554,778 Added 48.57%
4,756,000 $50.9 Million
Q2 2019

Aug 14, 2019

BUY
$7.58 - $10.0 $11.4 Million - $15 Million
1,500,000 Added 88.17%
3,201,222 $26.3 Million
Q1 2019

May 15, 2019

BUY
$5.81 - $9.37 $9.88 Million - $15.9 Million
1,701,222 New
1,701,222 $13.1 Million
Q4 2018

Feb 14, 2019

SELL
$5.75 - $21.85 $16.7 Million - $63.4 Million
-2,900,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$20.86 - $26.6 $16.6 Million - $21.1 Million
794,820 Added 37.76%
2,900,000 $66.9 Million
Q4 2017

Feb 14, 2018

BUY
$20.9 - $49.36 $30.3 Million - $71.5 Million
1,449,283 Added 220.96%
2,105,180 $51.8 Million
Q3 2017

Nov 13, 2017

BUY
$39.62 - $46.17 $26 Million - $30.3 Million
655,897
655,897 $27.8 Million

Others Institutions Holding DBVT

About DBV Technologies S.A.


  • Ticker DBVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,776,992
  • Market Cap $836M
  • Description
  • DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...
More about DBVT
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.